Cloning and antibacterial activity analysis of KL2 type Acinetobacter baumannii bacteriophage depolymerase
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference [40]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    [Background] Bacteriophage depolymerase is a kind of antibacterial protein produced by bacteriophage in the process of bacterial lysis. There are few reports on the capsule typing and common types of Acinetobacter baumannii bacteriophage depolymerases. [Objective] The KL2 type A. baumannii was selected as the research object. The depolymerase was cloned from the phage IME-AB2, and soluble expression was carried out in Escherichia coli, and its activity in vitro was studied. [Methods] A. baumannii capsular typing was identified through next generation sequencing and bioinformatics analysis. The IME-AB2 whole genome was analyzed. The putative tail fiber gene of ORF76 was cloned. The recombinant expression vector pEASY-Blunt-E1-gp76 was constructed and induced to express in E. coli BL21(DE3). The depolymerase was purified by Ni-NTA affinity chromatography and the gp76 antibacterial activity was studied in vitro. [Results] The recombinant plasmid of pEASY-Blunt-E1-gp76 was successfully constructed and expressed in E. coli. In vitro activity analysis was showed that the recombinant protein had good antibacterial activity against all KL2 type A. baumannii in vitro, and the depolymerase combined with human or dog serum had good bactericidal activity. [Conclusion] It is of great significance to identify depolymerase and improve its antibacterial spectrum, and it is also one of the important problems to be solved urgently in the field of bacteriophage and depolymerase used in the treatment of drug-resistant bacteria.

    Reference
    [1] Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B. Clinical and pathophysiological overview of Acinetobacter infections:a century of challenges[J]. Clinical Microbiology Reviews, 2017, 30(1):409-447
    [2] Ayobami O, Willrich N, Harder T, Okeke IN, Eckmanns T, Markwart R. The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, Eastern Mediterranean and Africa:a systematic review and meta-analysis[J]. Emerging Microbes & Infections, 2019, 8(1):1747-1759
    [3] Zeighami H, Valadkhani F, Shapouri R, Samadi E, Haghi F. Virulence characteristics of multidrug resistant biofilm forming Acinetobacter baumannii isolated from intensive care unit patients[J]. BMC Infectious Diseases, 2019, 19(1):629
    [4] Esterly JS, Griffith M, Qi C, Malczynski M, Postelnick MJ, Scheetz MH. Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections[J]. Antimicrobial Agents and Chemotherapy, 2011, 55(10):4844-4849
    [5] Rai S, Kumar A. Bacteriophage therapeutics to confront multidrug-resistant Acinetobacter baumannii-a global health menace[J]. Environmental Microbiology Reports, 2021:1758-2229.12988
    [6] Nilsson AS. Phage therapy-constraints and possibilities[J]. Upsala Journal of Medical Sciences, 2014, 119(2):192-198
    [7] Chan BK, Abedon ST, Loc-Carrillo C. Phage cocktails and the future of phage therapy[J]. Future Microbiology, 2013, 8(6):769-783
    [8] Yuan YY, Wang LL, Li XY, Tan DM, Cong C, Xu YP. Efficacy of a phage cocktail in controlling phage resistance development in multidrug resistant Acinetobacter baumannii[J]. Virus Research, 2019, 272:197734
    [9] Wang C, Li PY, Niu WK, Yuan X, Liu HY, Huang Y, An XP, Fan H, Zhangxiang LL, Mi LY, et al. Protective and therapeutic application of the depolymerase derived from a novel KN1 genotype of Klebsiella pneumoniae bacteriophage in mice[J]. Research in Microbiology, 2019, 170(3):156-164
    [10] Oliveira H, Costa AR, Ferreira A, Konstantinides N, Santos SB, Boon M, Noben JP, Lavigne R, Azeredo J. Functional analysis and antivirulence properties of a new depolymerase from a myovirus that infects Acinetobacter baumannii capsule K45[J]. Journal of Virology, 2019, 93(4). DOI:10.1128/jvi.01163-18
    [11] Wang C, Li PY, Zhu Y, Huang Y, Gao MM, Yuan X, Niu WK, Liu HY, Fan H, Qin YH, et al. Identification of a novel Acinetobacter baumannii phage-derived depolymerase and its therapeutic application in mice[J]. Frontiers in Microbiology, 2020, 11:1407
    [12] Popova AV, Shneider MM, Arbatsky NP, Kasimova AA, Senchenkova SN, Shashkov AS, Dmitrenok AS, Chizhov AO, Mikhailova YV, Shagin DA, et al. Specific interaction of novel Friunavirus phages encoding tailspike depolymerases with corresponding Acinetobacter baumannii capsular types[J]. Journal of Virology, 2021. DOI:10.1128/jvi.01714-20
    [13] Kenyon JJ, Kasimova AA, Shneider MM, Shashkov AS, Arbatsky NP, Popova AV, Miroshnikov KA, Hall RM, Knirel YA. The KL24 gene cluster and a genomic island encoding a Wzy polymerase contribute genes needed for synthesis of the K24 capsular polysaccharide by the multiply antibiotic resistant Acinetobacter baumannii isolate RCH51[J]. Microbiology, 2017, 163(3):355-363
    [14] Arbatsky NP, Shneider MM, Dmitrenok AS, Popova AV, Shagin DA, Shelenkov AA, Mikhailova YV, Edelstein MV, Knirel YA. Structure and gene cluster of the K125 capsular polysaccharide from Acinetobacter baumannii MAR13-1452[J]. International Journal of Biological Macromolecules, 2018, 117:1195-1199
    [15] Peng F, Mi ZQ, Huang Y, Yuan X, Niu WK, Wang YH, Hua YH, Fan HH, Bai CQ, Tong YG. Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates[J]. BMC Microbiology, 2014, 14(1):181
    [16] Liu YN, Mi ZQ, Mi LY, Huang Y, Li PY, Liu HY, Yuan X, Niu WK, Jiang N, Bai CQ, et al. Identification and characterization of capsule depolymerase Dpo48 from Acinetobacter baumannii phage IME200[J]. PeerJ, 2019, 7:e6173
    [17] Chen YB, Guo GH, Sun EC, Song JY, Yang L, Zhu LL, Liang W, Hua L, Peng Z, Tang XB, et al. Isolation of a T7-like lytic Pasteurella bacteriophage vB_PmuP_PHB01 and its potential use in therapy against Pasteurella multocida infections[J]. Viruses, 2019, 11(1):86
    [18] Chen YB, Sun EC, Song JY, Yang L, Wu B. Complete genome sequence of a novel T7-like bacteriophage from a Pasteurella multocida capsular type A isolate[J]. Current Microbiology, 2018, 75(5):574-579
    [19] Chang Y, Kim M, Ryu S. Characterization of a novel endolysin LysSA11 and its utility as a potent biocontrol agent against Staphylococcus aureus on food and utensils[J]. Food Microbiology, 2017, 68:112-120
    [20] Chang Y, Yoon H, Kang DH, Chang PS, Ryu S. Endolysin LysSA97 is synergistic with carvacrol in controlling Staphylococcus aureus in foods[J]. International Journal of Food Microbiology, 2017, 244:19-26
    [21] Thummeepak R, Kitti T, Kunthalert D, Sitthisak S. Enhanced antibacterial activity of Acinetobacter baumannii bacteriophage ØABP-01 endolysin (LysABP-01) in combination with colistin[J]. Frontiers in Microbiology, 2016, 7:1402
    [22] Oliveira H, Vilas Boas D, Mesnage S, Kluskens LD, Lavigne R, Sillankorva S, Secundo F, Azeredo J. Structural and enzymatic characterization of ABgp46, a novel phage endolysin with broad anti-Gram-negative bacterial activity[J]. Frontiers in Microbiology, 2016, 7:208
    [23] Lin JC, Koh TH, Lee N, Fung CP, Chang FY, Tsai YK, Ip M, Siu LK. Genotypes and virulence in serotype K2Klebsiella pneumoniae from liver abscess and non-infectious carriers in Hong Kong, Singapore and Taiwan[J]. Gut Pathogens, 2014, 6(1):21
    [24] Popova AV, Shneider MM, Myakinina VP, Bannov VA, Edelstein MV, Rubalskii EO, Aleshkin AV, Fursova NK, Volozhantsev NV. Characterization of myophage AM24 infecting Acinetobacter baumannii of the K9 capsular type[J]. Archives of Virology, 2019, 164(5):1493-1497
    [25] Lin H, Paff ML, Molineux IJ, Bull JJ. Therapeutic application of phage capsule depolymerases against K1, K5, and K30 capsulated E. coli in mice[J]. Frontiers in Microbiology, 2017, 8:2257
    [26] Lin TL, Hsieh PF, Huang YT, Lee WC, Tsai YT, Su PA, Pan YJ, Hsu CR, Wu MC, Wang JT. Isolation of a bacteriophage and its depolymerase specific for K1 capsule of Klebsiella pneumoniae:implication in typing and treatment[J]. The Journal of infectious Diseases, 2014, 210(11):1734-1744
    [27] Hsieh PF, Lin HH, Lin TL, Chen YY, Wang JT. Two T7-like bacteriophages, K5-2 and K5-4, each encodes two capsule depolymerases:isolation and functional characterization[J]. Scientific Reports, 2017, 7(1):4624
    [28] Liu YN, Leung SSY, Guo YT, Zhao LL, Jiang N, Mi LY, Li PY, Wang C, Qin YH, Mi ZQ, et al. The capsule depolymerase Dpo48 rescues Galleria mellonella and mice from Acinetobacter baumannii systemic infections[J]. Frontiers in Microbiology, 2019, 10:545
    [29] Oliveira H, Costa AR, Konstantinides N, Ferreira A, Akturk E, Sillankorva S, Nemec A, Shneider M, Dötsch A, Azeredo J. Ability of phages to infect Acinetobacter calcoaceticus-Acinetobacter baumannii complex species through acquisition of different pectate lyase depolymerase domains[J]. Environmental Microbiology, 2017, 19(12):5060-5077
    [30] Shirmohammadlou N, Zeighami H, Haghi F, Kashefieh M. Resistance pattern and distribution of carbapenemase and antiseptic resistance genes among multidrug-resistant Acinetobacter baumannii isolated from intensive care unit patients[J]. Journal of Medical Microbiology, 2018, 67(10):1467-1473
    [31] Thummeepak R, Kongthai P, Leungtongkam U, Sitthisak S. Distribution of virulence genes involved in biofilm formation in multi-drug resistant Acinetobacter baumannii clinical isolates[J]. International microbiology:the Official Journal of the Spanish Society for Microbiology, 2016, 19(2):121-129
    [32] Qi LH, Li H, Zhang CF, Liang BB, Li J, Wang LG, Du XY, Liu XL, Qiu SF, Song HB. Relationship between antibiotic resistance, biofilm formation, and biofilm-specific resistance in Acinetobacter baumannii[J]. Frontiers in Microbiology, 2016, 7:483
    [33] Taylor CM, Roberts IS. Capsular polysaccharides and their role in virulence[J]. Contributions to Microbiology, 2005,12:55-66
    [34] Knirel YA, Shneider MM, Popova AV, Kasimova AA, Senchenkova SN, Shashkov AS, Chizhov AO. Mechanisms of Acinetobacter baumannii capsular polysaccharide cleavage by phage depolymerases[J]. Biochemistry:Moscow, 2020, 85(5):567-574
    [35] Majkowska-Skrobek G, Latka A, Berisio R, Squeglia F, Maciejewska B, Briers Y, Drulis-Kawa Z. Phage-borne depolymerases decrease Klebsiella pneumoniae resistance to innate defense mechanisms[J]. Frontiers in Microbiology, 2018, 9:2517
    [36] Leiman PG, Battisti AJ, Bowman VD, Stummeyer K, Mühlenhoff M, Gerardy-Schahn R, Scholl D, Molineux IJ. The structures of bacteriophages K1E and K1-5 explain processive degradation of polysaccharide capsules and evolution of new host specificities[J]. Journal of Molecular Biology, 2007, 371(3):836-849
    [37] Oliveira H, Mendes A, Fraga AG, Ferreira A, Pimenta AI, Mil-Homens D, Fialho AM, Pedrosa J, Azeredo J. K2 capsule depolymerase is highly stable, is refractory to resistance, and protects larvae and mice from Acinetobacter baumannii sepsis[J]. Applied and Environmental Microbiology, 2019, 85(17):e00934-19
    [38] Majkowska-Skrobek G, Łątka A, Berisio R, Maciejewska B, Squeglia F, Romano M, Lavigne R, Struve C, Drulis-Kawa Z. Capsule-targeting depolymerase, derived from Klebsiella KP36 phage, as a tool for the development of anti-virulent strategy[J]. Viruses, 2016, 8(12):324
    [39] Plebani M, Banfi G, Bernardini S, Bondanini F, Conti L, Dorizzi R, Ferrara FE, Mancini R, Trenti T. Serum or plasma? An old question looking for new answers[J]. Clinical Chemistry and Laboratory Medicine, 2020, 58(2):178-187
    [40] Chen FF, Wang GK, Griffin JI, Brenneman B, Banda NK, Holers VM, Backos DS, Wu LP, Moghimi SM, Simberg D. Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo[J]. Nature Nanotechnology, 2017, 12(4):387-393
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

WANG Can, GAO Mingming, YU Xinting, LIU Yannan, MI Zhiqiang. Cloning and antibacterial activity analysis of KL2 type Acinetobacter baumannii bacteriophage depolymerase[J]. Microbiology China, 2021, 48(9): 3141-3153

Copy
Share
Article Metrics
  • Abstract:585
  • PDF: 1362
  • HTML: 1620
  • Cited by: 0
History
  • Received:June 23,2021
  • Adopted:August 04,2021
  • Online: September 08,2021
Article QR Code